Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H36O6 |
InChIKeyDBGVVIGAVAIWRU-GYGPFBJXSA-N |
CAS Registry104855-20-1 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dermatitis, Allergic Contact | Preclinical | Germany | 10 Jun 2025 | |
| inflammatory dermatosis | Preclinical | Germany | 10 Jun 2025 |





